News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
523,074 Results
Type
Article (37206)
Company Profile (255)
Press Release (485613)
Section
Business (148593)
Career Advice (946)
Deals (31150)
Drug Delivery (75)
Drug Development (71583)
Employer Resources (72)
FDA (12460)
Job Trends (11082)
News (263791)
Policy (21723)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (5)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (10)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (4)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1977)
Academic (1)
Accelerated approval (3)
Adcomms (22)
Allergies (56)
Alliances (37287)
ALS (77)
Alzheimer's disease (1183)
Antibody-drug conjugate (ADC) (117)
Approvals (12453)
Artificial intelligence (182)
Autoimmune disease (14)
Automation (9)
Bankruptcy (224)
Best Places to Work (9116)
BIOSECURE Act (13)
Biosimilars (71)
Biotechnology (197)
Bladder cancer (52)
Brain cancer (26)
Breast cancer (237)
Cancer (1827)
Cardiovascular disease (125)
Career advice (806)
Career pathing (14)
CAR-T (150)
Cell therapy (430)
Cervical cancer (13)
Clinical research (57698)
Collaboration (655)
Compensation (280)
Complete response letters (22)
COVID-19 (1935)
CRISPR (38)
C-suite (160)
Cystic fibrosis (97)
Data (1610)
Denatured (9)
Depression (36)
Diabetes (187)
Diagnostics (4620)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (21)
Drug discovery (111)
Drug pricing (64)
Drug shortages (21)
Duchenne muscular dystrophy (64)
Earnings (60270)
Editorial (21)
Employer branding (11)
Employer resources (68)
Events (81324)
Executive appointments (518)
FDA (13289)
Featured Employer (44)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (563)
Gene editing (92)
Generative AI (16)
Gene therapy (298)
GLP-1 (574)
Government (2439)
Grass and pollen (1)
Guidances (34)
Healthcare (14144)
Huntington's disease (20)
IgA nephropathy (21)
Immunology and inflammation (91)
Indications (22)
Infectious disease (2020)
Inflammatory bowel disease (121)
Inflation Reduction Act (6)
Influenza (31)
Intellectual property (65)
Interviews (147)
IPO (13349)
IRA (22)
Job creations (2389)
Job search strategy (699)
Kidney cancer (10)
Labor market (10)
Layoffs (358)
Leadership (8)
Legal (4853)
Liver cancer (70)
Lung cancer (275)
Lymphoma (122)
Management (22)
Manufacturing (228)
MASH (54)
Medical device (8992)
Medtech (8997)
Mergers & acquisitions (18247)
Metabolic disorders (503)
Multiple sclerosis (58)
NASH (16)
Neurodegenerative disease (73)
Neuropsychiatric disorders (22)
Neuroscience (1604)
NextGen: Class of 2025 (4627)
Non-profit (2732)
Northern California (1919)
Now hiring (8)
Obesity (267)
Opinion (168)
Ovarian cancer (60)
Pain (60)
Pancreatic cancer (63)
Parkinson's disease (119)
Partnered (14)
Patents (138)
Patient recruitment (71)
Peanut (35)
People (43004)
Pharmaceutical (55)
Pharmacy benefit managers (7)
Phase I (18321)
Phase II (25603)
Phase III (19029)
Pipeline (770)
Podcasts (57)
Policy (60)
Postmarket research (2089)
Preclinical (7766)
Press Release (72)
Prostate cancer (85)
Psychedelics (37)
Radiopharmaceuticals (227)
Rare diseases (346)
Real estate (3941)
Recruiting (27)
Regulatory (15986)
Reports (23)
Research institute (1969)
Resumes & cover letters (148)
Rett syndrome (2)
RNA editing (1)
RSV (23)
Schizophrenia (56)
Series A (107)
Series B (61)
Service/supplier (7)
Sickle cell disease (55)
Southern California (1564)
Special edition (11)
Sponsored (24)
Startups (2799)
State (2)
Stomach cancer (14)
Supply chain (41)
The Weekly (48)
United States (16348)
Vaccines (428)
Venture capitalists (24)
Webinars (7)
Weight loss (197)
Women's health (17)
Worklife (5)
Date
Today (147)
Last 7 days (690)
Last 30 days (2761)
Last 365 days (30249)
2025 (5228)
2024 (30686)
2023 (34216)
2022 (44090)
2021 (46859)
2020 (42938)
2019 (33863)
2018 (25874)
2017 (25549)
2016 (24032)
2015 (28641)
2014 (21653)
2013 (17979)
2012 (18844)
2011 (19120)
2010 (18056)
Location
Africa (490)
Alabama (35)
Alaska (4)
Arizona (124)
Arkansas (7)
Asia (30553)
Australia (5194)
California (4294)
Canada (1536)
China (376)
Colorado (166)
Connecticut (211)
Delaware (93)
Europe (69460)
Florida (608)
Georgia (132)
Idaho (42)
Illinois (337)
India (18)
Indiana (205)
Iowa (2)
Japan (124)
Kansas (64)
Kentucky (23)
Louisiana (7)
Maine (51)
Maryland (558)
Massachusetts (3424)
Michigan (151)
Minnesota (291)
Mississippi (1)
Missouri (67)
Montana (22)
Nebraska (20)
Nevada (46)
New Hampshire (45)
New Jersey (1241)
New Mexico (25)
New York (1207)
North Carolina (784)
North Dakota (7)
Northern California (1919)
Ohio (147)
Oklahoma (11)
Oregon (18)
Pennsylvania (987)
Puerto Rico (3)
Rhode Island (16)
South America (732)
South Carolina (5)
Southern California (1564)
Tennessee (68)
Texas (610)
Utah (119)
Virginia (89)
Washington D.C. (30)
Washington State (444)
West Virginia (2)
Wisconsin (45)
523,074 Results for "somatix therapy corp acquired by cell genesys".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Press Releases
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
February 6, 2025
·
8 min read
Deals
AbbVie Triples Down on T Cell Therapies in Xilio Deal Worth Up to $2.1B
The pharma giant inked its third T cell engager deal of 2025 Wednesday—this time with Xilio Therapeutics for tumor-activated immunotherapies.
February 12, 2025
·
1 min read
·
Kate Goodwin
Press Releases
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
The Company will present at the Annual J.P. Morgan Healthcare Conference, providing business updates on its sarcoma franchise and other cell therapy pipeline assets Adaptimmune Allo-T program to be featured at the Biotech ShowCase(TM) and the Wuxi Global Forum 2025
January 13, 2025
·
5 min read
Career Advice
The Right Fit: What BMS, Intellia Look for in Cell and Gene Therapy Talent
When hiring job candidates to work on cell and gene therapies, companies look for more than just technical skills. Talent acquisition executives from Bristol Myers Squibb and Intellia Therapeutics offer an inside look at what they want in an employee.
December 12, 2024
·
5 min read
·
Angela Gabriel
Cell MedX Corp. Closes Private Placement Financing
Cell MedX Corp. (OTC Pink: CMXC) (“Cell MedX”, or the “Company”) a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products
March 19, 2024
·
3 min read
Cell MedX Corp. Announces Resignation of Director
Cell MedX Corp. (OTC Pink: CMXC) (“Cell MedX”, or the “Company”) a biotech company focusing on the discovery, development and commercialization of therapeutic
February 29, 2024
·
2 min read
Job trends
Cell Therapy Biotechs Hunt for Autoimmune Expertise in Pivot From Oncology
In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right expertise is in place to tackle the new disease area.
November 6, 2024
·
6 min read
·
Annalee Armstrong
Press Releases
Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies
November 26, 2024
·
13 min read
Drug development
5 Sickle Cell Therapies to Watch Following Pfizer’s Oxbryta Exit
In the wake of Pfizer’s voluntary market withdrawal of the popular sickle cell disease therapy,
BioSpace
looks at five investigational drugs currently making their way through the pipeline.
October 21, 2024
·
4 min read
·
Kate Goodwin
1 of 52,308
Next
